{
    "clinical_study": {
        "@rank": "46791", 
        "brief_summary": {
            "textblock": "The objective of the study is to assess patient's perception with stable state COPD on\n      symptom variability and to describe how symptom variability impacts daily quality of life in\n      Chinese COPD patient with moderate, severe or very severe airflow limitation from tier 3\n      hospitals in China where most of COPD patients are diagnosed and treated."
        }, 
        "brief_title": "Perception of Symptom Variability in COPD", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Chronic Obstructive Pulmonary Disease", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Provision of subject informed consent\n\n          -  Out-patient\n\n          -  Clinical diagnosis of COPD at least 6 months\n\n          -  Lung function based on data available within 3 months in medical records confirming\n             FEV1<80% normal predicted (post-bronchodilator) and FEV1/FVC<0.7\n             (post-bronchodilator)\n\n        Exclusion Criteria:\n\n          -  Participation in any interventional study involving investigational drugs; Patient\n             inability to understand the study procedures or inability/reluctance to answer\n             questionnaire\n\n          -  Ongoing exacerbation of COPD or exacerbation within the previous 3 months. An\n             exacerbation is defined as a worsening of COPD symptoms leading to a treatment with\n             antibiotics and/or a short course of system steroids and/or hospitalisation or\n             emergency\n\n          -  History of asthma and/or allergic rhinitis,  Lung cancer or any other significant\n             respiratory disease such as bronchiectasis, lung fibrosis, interstitial lung disease,\n             tuberculosis, sarcoidosis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Out-patient, male or female aged 40 years and over and Clinical diagnosis of COPD at least\n        6 months"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01753427", 
            "org_study_id": "NIS-RCN-XXX-2012/1"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "COPD,", 
            "symptoms,", 
            "Non-Interventional study,"
        ], 
        "lastchanged_date": "December 12, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China", 
                        "state": "Hubei"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China", 
                        "state": "Sichuan"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tianjin", 
                        "country": "China", 
                        "state": "Tianjin"
                    }, 
                    "name": "Research Site"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "Perception of Symptom Variability in Chinese COPD Patients", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "To ask subject,  which symptoms\uff08breathlessness, chest tightness, coughing, wheezing, phlegm\uff09is COPD symptoms and exist throughout the day\nTo ask subject , whether COPD symptoms variability throughout the day exists or not ;\nTo ask subject , which (on waking, later in the morning, in the afternoon, in the evening, at night) is the most likely occurring time of these symptoms;\nTo ask subject , Which (on waking, later in the morning, in the afternoon, in the evening, at night) is the most troublesome time of these symptoms.", 
            "measure": "The variability of symptoms due to COPD throughout the day", 
            "safety_issue": "No", 
            "time_frame": "Day 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01753427"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To ask subject,  Whether essential daily activities  affected by COPD symptoms and the type of  following: going up and downstairs, Going out of shopping, doing sport/exercise, doing housework, or all of these\nTo ask subject, Whether sleep quality affected by COPD symptoms and the type of  following: difficulty falling sleep, frequent waking during night,  early waking in the morning, or all of these", 
                "measure": "The impact of COPD symptoms on patient's daily living activities and sleep quality", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "To ask subject, When [getting out of bed, dressing, washing, eating breakfast, morning activity after breakfast (indoor activity, including housework) , morning exercise (outdoor activity, such as walking, sport, etc)] the essential morning activities affected by COPD symptoms:\nTo ask subject, The extent of these morning activities affected: not at all, a little, moderate, severe,  extremely severe resulting to feel difficult to complete independently, extremely severe resulting to complete under others help  or cannot complete at all", 
                "measure": "The impact of COPD symptoms on morning activities", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "CAT (COPD assessment test) has a broader coverage of the impact of COPD on the patient's daily life and well-being.", 
                "measure": "Total CAT score", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "MMRC (Modified Medical Research Council Questionnaire for Assessing the Severity of Breathlessness) assesses disability due to breathlessness.", 
                "measure": "Total MMRC score", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "description": "To ask subject, Seek for treatment only when symptoms occur/worsening or regularly visit physician and take medicine(s)\nTo ask subject, Whether Knowing about how and when to use their medications\nTo ask subject, Usually taking their medication(s) required by physician to be used in the morning at what time: before getting out of bed,  within 30 minutes after getting out of bed, within 30 minutes to 1 hour after getting out of bed, over 1 hour after getting out of bed, no regular time", 
                "measure": "Patient's perception on COPD and COPD treatments", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }
        ], 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}